Raiffeisen Bank International AG Lowers Stock Position in HCA Healthcare, Inc. $HCA

Raiffeisen Bank International AG trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 28.1% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 10,251 shares of the company’s stock after selling 4,011 shares during the period. Raiffeisen Bank International AG’s holdings in HCA Healthcare were worth $4,022,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the business. BlackRock Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $5,069,974,000. State Street Corp raised its position in HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after acquiring an additional 76,039 shares during the period. Capital World Investors increased its stake in shares of HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after purchasing an additional 40,086 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock valued at $1,835,397,000 after buying an additional 799,761 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after purchasing an additional 13,565 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Down 1.0%

Shares of NYSE HCA opened at $404.95 on Friday. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The firm has a market capitalization of $87.67 billion, a P/E ratio of 13.56, a P/E/G ratio of 1.35 and a beta of 1.10. The stock’s 50-day simple moving average is $403.35 and its two-hundred day simple moving average is $437.55.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business earned $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s payout ratio is currently 10.45%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. UBS Group reduced their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Cantor Fitzgerald reduced their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. JPMorgan Chase & Co. cut their target price on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research note on Thursday, August 20th. Barclays lowered their price target on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Finally, Wells Fargo & Company boosted their price objective on shares of HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.